Lilly to acquire Centessa Pharmaceuticals to advance treatments for sleep-wake disorders

Apr 02 2026
Lilly to acquire Centessa Pharmaceuticals to advance treatments for sleep-wake disorders

INDIANAPOLIS and BOSTON and LONDON, March 31, 2026 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) and Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage company developing a new class of medicines for the treatment of excessive daytime sleepiness and other neurological conditions, today announced a definitive agreement for Lilly to acquire Centessa.

Check out the full article here.